Pyrazole compounds represented by the formula:
##STR1##
are described. The pyrazole compounds and pharmaceutical compositions containing
them may be used in inhibiting ERAB or HADH2 activity and in treating ERAB, HADH2
or amyloid- mediated diseases and conditions.